1. Liamis G, Milionis HJ, Elisaf M (2010) Medication-induced hypophosphatemia: a review. QJM, 103(7): 449-459. [ DOI:10.1093/qjmed/hcq039] [ PMID] 2. Herzog P and Holtermüller KH (1982) Antacid therapy--changes in mineral metabolism. Scand J Gastroenterol Suppl, 75: 56-62. 3. Megapanou E, Florentin M, Milionis H, Elisaf M, Liamis G (2020) Drug-Induced Hypophosphatemia: Current Insights. Drug Saf, 43(3): 197-210. [ DOI:10.1007/s40264-019-00888-1] [ PMID] 4. Serna J and Bergwitz C (2020) Importance of Dietary Phosphorus for Bone Metabolism and Healthy Aging. Nutrients, 12(10): 3001. [ DOI:10.3390/nu12103001] [ PMID] [ ] 5. Cooke N, Teitelbaum S, Avioli LV (1978) Antacid-induced osteomalacia and nephrolithiasis. Arch Intern Med, 138(6): 1007-1009. [ DOI:10.1001/archinte.1978.03630310083028] 6. Boutsen Y, Devogelaer JP, Malghem J, Noel H, Nagant de Deuxchaisnes C (1996) Antacid-induced osteomalacia. Clin Rheumatol, 15(1): 75-80. [ DOI:10.1007/BF02231691] [ PMID] 7. Chines A and Pacifici R (1990) Antacid and sucralfate-induced hypophosphatemic osteomalacia: a case report and review of the literature. Calcif Tissue Int, 47(5): 291-295. [ DOI:10.1007/BF02555911] [ PMID] 8. Kassem M, Eriksen EF, Melsen F, Mosekilde L (1991) Antacid-induced osteomalacia: a case report with a histomorphometric analysis. J Intern Med, 229(3): 275-279. [ DOI:10.1111/j.1365-2796.1991.tb00344.x] [ PMID] 9. Woodson GC (1998) An interesting case of osteomalacia due to antacid use associated with stainable bone aluminum in a patient with normal renal function. Bone, 22(6): 695-698. [ DOI:10.1016/S8756-3282(98)00060-X] 10. Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, Collins MT (2017) Tumour-induced osteomalacia. Nat Rev Dis Primers, 3: 17044. [ DOI:10.1038/nrdp.2017.44] [ PMID] 11. Aligail K, Dave JA, Ross IL (2022) Tumor-induced osteomalacia: a case report. J Med Case Rep, 16(1): 22. [ DOI:10.1186/s13256-021-03220-7] [ PMID] [ ] 12. Yin Z, Du J, Yu F, Xia W (2018) Tumor-induced osteomalacia. Osteoporos Sarcopenia, 4(4): 119-127. [ DOI:10.1016/j.afos.2018.12.001] [ PMID] [ ] 13. Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, Collins MT (2017) Tumour-induced osteomalacia. Nat Rev Dis Primers, 3: 17044. [ DOI:10.1038/nrdp.2017.44] [ PMID] 14. Velazquez-Navarro JA, Loya-Teruel E, Rios-Gomez M, Montes-Ramirez JE (2022) Tumor-Induced Osteomalacia With Normal Fibroblast Growth Factor-23 (FGF23) and Idiopathic Hypercalciuria. Cureus, 14(1): e20893. [ DOI:10.7759/cureus.20893] [ PMID] [ ] 15. Beil FT, Stürznickel J, Rolvien T, Amling M, Oheim R (2022) Tumor localization and treatment of tumor-induced osteomalacia. Z Rheumatol, 81(3): 182-188. [ DOI:10.1007/s00393-022-01160-1] [ PMID] 16. Ukinc K (2009) Severe osteomalacia presenting with multiple vertebral fractures: a case report and review of the literature. Endocrine, 36(1): 30-36. [ DOI:10.1007/s12020-009-9209-8] [ PMID] 17. Kim SH, Won KS, Song BI, Jo I, Zeon SK (2013) Low-dose adefovir-induced hypophosphatemic osteomalacia on whole-body bone scintigraphy. Nucl Med Mol Imaging, 47(4): 294-296. [ DOI:10.1007/s13139-013-0223-7] [ PMID] [ ] 18. Tanaka M, Setoguchi T, Ishidou Y, Arishima Y, Hirotsu M, Saitoh Y, et al. (2012) Pathological femoral fractures due to osteomalacia associated with adefovir dipivoxil treatment for hepatitis B: a case report. Diagn Pathol, 7: 108. [ DOI:10.1186/1746-1596-7-108] [ PMID] [ ] 19. Sood A, Agarwal K, Shukla J, Goel R, Dhir V, Bhattacharya A, Rai Mittal B (2013) Bone scintigraphic patterns in patients of tumor induced osteomalacia. Indian J Nucl Med, 28(3): 173-5. [ DOI:10.4103/0972-3919.119541] [ PMID] [ ] 20. Sadineni RT, Pasumarthy A, Bellapa NC, Velicheti S (2015) Imaging Patterns in MRI in Recent Bone Injuries Following Negative or Inconclusive Plain Radiographs. J Clin Diagn Res, 9(10): TC10-TC13. [ DOI:10.7860/JCDR/2015/15451.6685] [ PMID] [ ]
|